共 207 条
[1]
Murphy G(2013)Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment Lancet 382 809-818
[2]
Lisnevskaia L(2019)Systemic lupus erythematosus: diagnosis and clinical management J Autoimmun 96 1-13
[3]
Isenberg D(2010)European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies Ann Rheum Dis 69 1269-1274
[4]
Fava A(2019)2019 update of the EULAR recommendations for the management of systemic lupus erythematosus Ann Rheum Dis 78 736-745
[5]
Petri M(2016)Longitudinal evaluation of lipoprotein parameters in systemic lupus erythematosus reveals adverse changes with disease activity and prednisone and more favorable profiles with hydroxychloroquine therapy J Rheumatol 43 745-750
[6]
Mosca M(2019)Systemic lupus erythematosus and increased prevalence of atherosclerotic cardiovascular disease in hospitalized patients Mayo Clin Proc 94 1436-1443
[7]
Tani C(2018)Favorable effects of hydroxychloroquine on serum low density lipid in patients with systemic lupus erythematosus: a systematic review and meta-analysis Int J Rheum Dis 21 84-92
[8]
Aringer M(2019)Long-term hydroxychloroquine therapy and risk of coronary artery disease in patients with systemic lupus erythematosus J Clin Med 8 796-103
[9]
Bombardieri S(2018)Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis Ann Rheum Dis 77 98-2343
[10]
Boumpas D(2015)Antidiabetogenic effects of hydroxychloroquine on insulin sensitivity and beta cell function: a randomised trial Diabetologia 58 2336-1261